Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
How we work:
- PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
- COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
- BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
How you’ll make an impact:
- Drive Kymera's business development strategy, positioning our targeted protein degradation platform and pipeline at the center of strategic partnerships.
- Identify, evaluate, and close strategic transactions with leading biopharma companies— spanning both buy- and sell-side opportunities.
- Own transactions end to end, from initial opportunity through signature agreement, working closely with R&D, legal, finance, and outside counsel.
- Lead and coordinate cross-functional diligence teams.
- Prepare high-quality partnering materials, including presentations, term sheets, valuation models to support transaction processes.
- Lead search and evaluation processes for prioritized external opportunities.
- Develop financial analyses, including forecasts, comparables, and NPV valuations, to inform critical decisions.
- Lead negotiation and execution of collaboration agreements (licensing and collaboration agreements, SRAs, MTAs, and CDAs) in close partnership with internal and external council.
- Represent Kymera in the industry, building relationships with BD counterparts at current and potential partner companies
- Represent Kymera at partnering conferences and industry events (eg. JPM, BIO) to build and maintain relationships with potential partners and support S&E activity.
Skills and experience you’ll bring:
- An advanced degree — PhD, MD, or MBA — that reflects both scientific fluency and business acumen.
- 8+ years of experience in business development, corporate development, or strategy consulting in biopharma.
- Experience across the full deal lifecycle: sourcing, diligence, negotiation, and structuring.
- Demonstrated success working with cross-functional teams and managing multiple concurrent projects
- Strong strategic judgment, the ability to work independently and represent Kymera externally
- NPV modeling, forecasting, and comparables analysis with the ability to communicate results clearly.
- A track record of evaluating opportunities from both a scientific and commercial perspective.
- Working knowledge of biopharma R&D (experience with small molecules is a plus), clinical development, and regulatory pathways
- Excellent negotiation, written, and presentation skills.
Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.
Compensation
- Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
- The anticipated base salary range for this role is $195,000 – $275,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
- Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate’s depth of experience and the capabilities they bring to the position.
Skills Required
- Advanced degree (PhD, MD, or MBA)
- 8+ years of business development, corporate development, or strategy consulting experience in biopharma
- Experience across full deal lifecycle: sourcing, diligence, negotiation, and structuring
- Proven ability to lead and coordinate cross-functional diligence teams (R&D, legal, finance, outside counsel)
- Prepare high-quality partnering materials, including presentations, term sheets, and valuation models
- Financial analysis skills: NPV modeling, forecasting, and comparables analysis
- Experience negotiating and executing collaboration agreements (licensing, SRAs, MTAs, CDAs)
- Working knowledge of biopharma R&D, clinical development, and regulatory pathways
- Experience with small molecules
- Excellent negotiation, written, and presentation skills
- Experience representing the company at partnering conferences and building BD relationships
Kymera Therapeutics Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Kymera Therapeutics and has not been reviewed or approved by Kymera Therapeutics.
-
Fair & Transparent Compensation — Pay is considered market‑competitive for core scientific and leadership roles, with clearly posted ranges visible for U.S. openings. Feedback suggests strong base pay aligns with comments about high salary and good pay.
-
Equity Value & Accessibility — Employees are eligible to participate in broad‑based equity programs, including an equity incentive plan and an ESPP. Feedback suggests this ownership opportunity can meaningfully augment total compensation in a growth‑focused setting.
-
Leave & Time Off Breadth — Company‑wide office shutdowns, standard PTO, and summer schedules are promoted to help people unplug. Feedback suggests these practices contribute to a well‑rounded time‑off offering.
Kymera Therapeutics Insights
What We Do
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years








